FDMT
4D Molecular Therapeutics Inc
15.00$
-5.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +254.9% | -39.9% | +395.1% | +22.6% | -25.9% | +29.8% | +64.9% | +1.1% | |
| – | +284.0% | -44.2% | +438.3% | -9.3% | -14.0% | +34.5% | +46.6% | -5.0% | |
| – | +284.7% | -45.9% | +457.3% | -44.7% | -65.8% | +375.8% | -40.1% | -59.7% | |
| – | +284.7% | -45.9% | +457.3% | -10.5% | -13.8% | +35.0% | +47.4% | -5.2% | |
| – | +250.2% | -13.0% | +51.9% | -96.8% | +1,389.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | -9.0% | +104.2% | +0.5% | +470.7% | -23.1% | – | – | – | |
| – | +165.5% | +5.3% | -75.7% | +7.6% | -11.3% | +5.1% | +55.3% | +22.6% | |
| – | +36.3% | +60.9% | +29.2% | -2.4% | -3.7% | +20.5% | +53.8% | +50.9% | |
| – | +82.4% | – | – | – | +115.7% | +18.6% | +79.0% | -0.8% | |
| – | +107.4% | +82.8% | +2.5% | +166.6% | -30.3% | +5.8% | +24.8% | +154.4% | |
| – | – | – | – | +24.5% | -27.5% | +33.1% | +65.9% | -1.0% | |
| – | – | – | – | – | – | – | – | – | |
| – | -15.6% | +111.6% | +0.7% | +3.9% | +16.7% | +21.0% | +37.9% | +7.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.